Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-06

Clinical Trial Update: Regimen Transition After Short-Term Intensive Insulin Therapy in Type 2 Diabetes [Phase 4]

View source ↗

Summary

This Phase 4 clinical trial update discusses regimen transition after short-term intensive insulin therapy in adults with type 2 diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Insulin (insulin)

Snippet

Sponsor: Yanbing Li | Conditions: Type 2 Diabetes | Phase 4 | Status: NOT_YET_RECRUITING